期刊文献+

糖链抗原19-9放免测定对诊断胃肠道潜隐癌的价值 被引量:10

Role of Carbohydrate Antigen 19-9(CA19-9) Radioimmunometric Assay in the Diagnosis of Gastrointestinal Occult Carcinoma
暂未订购
导出
摘要 对胃肠道潜隐癌、癌前病变和炎性病变各30例患者术前的糖链抗原(CA)19-9水平进行回顾性分析,发现3组之间或两两比较均有明显差异。发现<37u/ml者97.44%为良性病变,>90u/ml者94.44%为恶性病变。37~90u/ml之间者复查前后对比,癌变组血清CA19-9水平平均升高14.42u/ml,良性病变组平均下降9.62u/ml。提示对经内镜活组织检查未被证实的可疑胃肠道肿瘤患者,常规CA19-9放免测定有助于发现胃肠道潜隐癌。 Preoperative serum CA 19-9 levels in 30 patients with various gastrointestinal disorders such as occult carcinoma(GIOC),precancerous lesions and inflammatory changes were analysed. Marked differences were found in between these conditions. Serum CA 19-9 level in 97. 44% of benign patients was<37u/ml and that of 94.44% of malignant patients was>90u/ml. In light of these results it is suggested that CA 19-9 RIA may be helpful in the diagnosis of GIOC in case a patient is suspicious of having cancer after endoscopic biopsy.
机构地区 河北省人民医院
出处 《中国肿瘤临床》 CAS CSCD 北大核心 1995年第5期312-314,共3页 Chinese Journal of Clinical Oncology
关键词 CA19-9 放免测定 胃肠道肿瘤 潜隐癌 Carbohydrate antigen 19-9 Radioimmunometric assay Occult gastrointestinal carcinoma
  • 相关文献

同被引文献33

引证文献10

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部